Global Large Molecule Drug Substance CDMO Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Large Molecule Drug Substance CDMO market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Large Molecule Drug Substance CDMO market are covered in Chapter 9:
Samsung Biologics
Eurofins Scientific
AGC Biologics
Catalent, Inc.
Siegfried Holding AG
LabCorp Drug Development, and FUJIFILM Diosynth Biotechnologies
Cambrex Corp.
WuXi Biologics
Recipharm AB (publ)
In Chapter 5 and Chapter 7.3, based on types, the Large Molecule Drug Substance CDMO market from 2017 to 2027 is primarily split into:
Contract Manufacturing
Contract Development
In Chapter 6 and Chapter 7.4, based on applications, the Large Molecule Drug Substance CDMO market from 2017 to 2027 covers:
Biotech Companies
CRO
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Large Molecule Drug Substance CDMO market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Large Molecule Drug Substance CDMO Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Large Molecule Drug Substance CDMO market are covered in Chapter 9:
Samsung Biologics
Eurofins Scientific
AGC Biologics
Catalent, Inc.
Siegfried Holding AG
LabCorp Drug Development, and FUJIFILM Diosynth Biotechnologies
Cambrex Corp.
WuXi Biologics
Recipharm AB (publ)
In Chapter 5 and Chapter 7.3, based on types, the Large Molecule Drug Substance CDMO market from 2017 to 2027 is primarily split into:
Contract Manufacturing
Contract Development
In Chapter 6 and Chapter 7.4, based on applications, the Large Molecule Drug Substance CDMO market from 2017 to 2027 covers:
Biotech Companies
CRO
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Large Molecule Drug Substance CDMO market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Large Molecule Drug Substance CDMO Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 LARGE MOLECULE DRUG SUBSTANCE CDMO MARKET OVERVIEW
1.1 Product Overview and Scope of Large Molecule Drug Substance CDMO Market
1.2 Large Molecule Drug Substance CDMO Market Segment by Type
1.2.1 Global Large Molecule Drug Substance CDMO Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Large Molecule Drug Substance CDMO Market Segment by Application
1.3.1 Large Molecule Drug Substance CDMO Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Large Molecule Drug Substance CDMO Market, Region Wise (2017-2027)
1.4.1 Global Large Molecule Drug Substance CDMO Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Large Molecule Drug Substance CDMO Market Status and Prospect (2017-2027)
1.4.3 Europe Large Molecule Drug Substance CDMO Market Status and Prospect (2017-2027)
1.4.4 China Large Molecule Drug Substance CDMO Market Status and Prospect (2017-2027)
1.4.5 Japan Large Molecule Drug Substance CDMO Market Status and Prospect (2017-2027)
1.4.6 India Large Molecule Drug Substance CDMO Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Large Molecule Drug Substance CDMO Market Status and Prospect (2017-2027)
1.4.8 Latin America Large Molecule Drug Substance CDMO Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Large Molecule Drug Substance CDMO Market Status and Prospect (2017-2027)
1.5 Global Market Size of Large Molecule Drug Substance CDMO (2017-2027)
1.5.1 Global Large Molecule Drug Substance CDMO Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Large Molecule Drug Substance CDMO Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Large Molecule Drug Substance CDMO Market
2 INDUSTRY OUTLOOK
2.1 Large Molecule Drug Substance CDMO Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Large Molecule Drug Substance CDMO Market Drivers Analysis
2.4 Large Molecule Drug Substance CDMO Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Large Molecule Drug Substance CDMO Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Large Molecule Drug Substance CDMO Industry Development
3 GLOBAL LARGE MOLECULE DRUG SUBSTANCE CDMO MARKET LANDSCAPE BY PLAYER
3.1 Global Large Molecule Drug Substance CDMO Sales Volume and Share by Player (2017-2022)
3.2 Global Large Molecule Drug Substance CDMO Revenue and Market Share by Player (2017-2022)
3.3 Global Large Molecule Drug Substance CDMO Average Price by Player (2017-2022)
3.4 Global Large Molecule Drug Substance CDMO Gross Margin by Player (2017-2022)
3.5 Large Molecule Drug Substance CDMO Market Competitive Situation and Trends
3.5.1 Large Molecule Drug Substance CDMO Market Concentration Rate
3.5.2 Large Molecule Drug Substance CDMO Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL LARGE MOLECULE DRUG SUBSTANCE CDMO SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Large Molecule Drug Substance CDMO Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Large Molecule Drug Substance CDMO Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Large Molecule Drug Substance CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Large Molecule Drug Substance CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Large Molecule Drug Substance CDMO Market Under COVID-19
4.5 Europe Large Molecule Drug Substance CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Large Molecule Drug Substance CDMO Market Under COVID-19
4.6 China Large Molecule Drug Substance CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Large Molecule Drug Substance CDMO Market Under COVID-19
4.7 Japan Large Molecule Drug Substance CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Large Molecule Drug Substance CDMO Market Under COVID-19
4.8 India Large Molecule Drug Substance CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Large Molecule Drug Substance CDMO Market Under COVID-19
4.9 Southeast Asia Large Molecule Drug Substance CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Large Molecule Drug Substance CDMO Market Under COVID-19
4.10 Latin America Large Molecule Drug Substance CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Large Molecule Drug Substance CDMO Market Under COVID-19
4.11 Middle East and Africa Large Molecule Drug Substance CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Large Molecule Drug Substance CDMO Market Under COVID-19
5 GLOBAL LARGE MOLECULE DRUG SUBSTANCE CDMO SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Large Molecule Drug Substance CDMO Sales Volume and Market Share by Type (2017-2022)
5.2 Global Large Molecule Drug Substance CDMO Revenue and Market Share by Type (2017-2022)
5.3 Global Large Molecule Drug Substance CDMO Price by Type (2017-2022)
5.4 Global Large Molecule Drug Substance CDMO Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Large Molecule Drug Substance CDMO Sales Volume, Revenue and Growth Rate of Contract Manufacturing (2017-2022)
5.4.2 Global Large Molecule Drug Substance CDMO Sales Volume, Revenue and Growth Rate of Contract Development (2017-2022)
6 GLOBAL LARGE MOLECULE DRUG SUBSTANCE CDMO MARKET ANALYSIS BY APPLICATION
6.1 Global Large Molecule Drug Substance CDMO Consumption and Market Share by Application (2017-2022)
6.2 Global Large Molecule Drug Substance CDMO Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Large Molecule Drug Substance CDMO Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Large Molecule Drug Substance CDMO Consumption and Growth Rate of Biotech Companies (2017-2022)
6.3.2 Global Large Molecule Drug Substance CDMO Consumption and Growth Rate of CRO (2017-2022)
6.3.3 Global Large Molecule Drug Substance CDMO Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL LARGE MOLECULE DRUG SUBSTANCE CDMO MARKET FORECAST (2022-2027)
7.1 Global Large Molecule Drug Substance CDMO Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Large Molecule Drug Substance CDMO Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Large Molecule Drug Substance CDMO Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Large Molecule Drug Substance CDMO Price and Trend Forecast (2022-2027)
7.2 Global Large Molecule Drug Substance CDMO Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Large Molecule Drug Substance CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Large Molecule Drug Substance CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Large Molecule Drug Substance CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Large Molecule Drug Substance CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Large Molecule Drug Substance CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Large Molecule Drug Substance CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Large Molecule Drug Substance CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Large Molecule Drug Substance CDMO Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Large Molecule Drug Substance CDMO Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Large Molecule Drug Substance CDMO Revenue and Growth Rate of Contract Manufacturing (2022-2027)
7.3.2 Global Large Molecule Drug Substance CDMO Revenue and Growth Rate of Contract Development (2022-2027)
7.4 Global Large Molecule Drug Substance CDMO Consumption Forecast by Application (2022-2027)
7.4.1 Global Large Molecule Drug Substance CDMO Consumption Value and Growth Rate of Biotech Companies(2022-2027)
7.4.2 Global Large Molecule Drug Substance CDMO Consumption Value and Growth Rate of CRO(2022-2027)
7.4.3 Global Large Molecule Drug Substance CDMO Consumption Value and Growth Rate of Others(2022-2027)
7.5 Large Molecule Drug Substance CDMO Market Forecast Under COVID-19
8 LARGE MOLECULE DRUG SUBSTANCE CDMO MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Large Molecule Drug Substance CDMO Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Large Molecule Drug Substance CDMO Analysis
8.6 Major Downstream Buyers of Large Molecule Drug Substance CDMO Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Large Molecule Drug Substance CDMO Industry
9 PLAYERS PROFILES
9.1 Samsung Biologics
9.1.1 Samsung Biologics Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Large Molecule Drug Substance CDMO Product Profiles, Application and Specification
9.1.3 Samsung Biologics Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Eurofins Scientific
9.2.1 Eurofins Scientific Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Large Molecule Drug Substance CDMO Product Profiles, Application and Specification
9.2.3 Eurofins Scientific Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 AGC Biologics
9.3.1 AGC Biologics Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Large Molecule Drug Substance CDMO Product Profiles, Application and Specification
9.3.3 AGC Biologics Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Catalent, Inc.
9.4.1 Catalent, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Large Molecule Drug Substance CDMO Product Profiles, Application and Specification
9.4.3 Catalent, Inc. Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Siegfried Holding AG
9.5.1 Siegfried Holding AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Large Molecule Drug Substance CDMO Product Profiles, Application and Specification
9.5.3 Siegfried Holding AG Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 LabCorp Drug Development, and FUJIFILM Diosynth Biotechnologies
9.6.1 LabCorp Drug Development, and FUJIFILM Diosynth Biotechnologies Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Large Molecule Drug Substance CDMO Product Profiles, Application and Specification
9.6.3 LabCorp Drug Development, and FUJIFILM Diosynth Biotechnologies Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Cambrex Corp.
9.7.1 Cambrex Corp. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Large Molecule Drug Substance CDMO Product Profiles, Application and Specification
9.7.3 Cambrex Corp. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 WuXi Biologics
9.8.1 WuXi Biologics Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Large Molecule Drug Substance CDMO Product Profiles, Application and Specification
9.8.3 WuXi Biologics Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Recipharm AB (publ)
9.9.1 Recipharm AB (publ) Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Large Molecule Drug Substance CDMO Product Profiles, Application and Specification
9.9.3 Recipharm AB (publ) Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Large Molecule Drug Substance CDMO Market
1.2 Large Molecule Drug Substance CDMO Market Segment by Type
1.2.1 Global Large Molecule Drug Substance CDMO Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Large Molecule Drug Substance CDMO Market Segment by Application
1.3.1 Large Molecule Drug Substance CDMO Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Large Molecule Drug Substance CDMO Market, Region Wise (2017-2027)
1.4.1 Global Large Molecule Drug Substance CDMO Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Large Molecule Drug Substance CDMO Market Status and Prospect (2017-2027)
1.4.3 Europe Large Molecule Drug Substance CDMO Market Status and Prospect (2017-2027)
1.4.4 China Large Molecule Drug Substance CDMO Market Status and Prospect (2017-2027)
1.4.5 Japan Large Molecule Drug Substance CDMO Market Status and Prospect (2017-2027)
1.4.6 India Large Molecule Drug Substance CDMO Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Large Molecule Drug Substance CDMO Market Status and Prospect (2017-2027)
1.4.8 Latin America Large Molecule Drug Substance CDMO Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Large Molecule Drug Substance CDMO Market Status and Prospect (2017-2027)
1.5 Global Market Size of Large Molecule Drug Substance CDMO (2017-2027)
1.5.1 Global Large Molecule Drug Substance CDMO Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Large Molecule Drug Substance CDMO Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Large Molecule Drug Substance CDMO Market
2 INDUSTRY OUTLOOK
2.1 Large Molecule Drug Substance CDMO Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Large Molecule Drug Substance CDMO Market Drivers Analysis
2.4 Large Molecule Drug Substance CDMO Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Large Molecule Drug Substance CDMO Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Large Molecule Drug Substance CDMO Industry Development
3 GLOBAL LARGE MOLECULE DRUG SUBSTANCE CDMO MARKET LANDSCAPE BY PLAYER
3.1 Global Large Molecule Drug Substance CDMO Sales Volume and Share by Player (2017-2022)
3.2 Global Large Molecule Drug Substance CDMO Revenue and Market Share by Player (2017-2022)
3.3 Global Large Molecule Drug Substance CDMO Average Price by Player (2017-2022)
3.4 Global Large Molecule Drug Substance CDMO Gross Margin by Player (2017-2022)
3.5 Large Molecule Drug Substance CDMO Market Competitive Situation and Trends
3.5.1 Large Molecule Drug Substance CDMO Market Concentration Rate
3.5.2 Large Molecule Drug Substance CDMO Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL LARGE MOLECULE DRUG SUBSTANCE CDMO SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Large Molecule Drug Substance CDMO Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Large Molecule Drug Substance CDMO Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Large Molecule Drug Substance CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Large Molecule Drug Substance CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Large Molecule Drug Substance CDMO Market Under COVID-19
4.5 Europe Large Molecule Drug Substance CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Large Molecule Drug Substance CDMO Market Under COVID-19
4.6 China Large Molecule Drug Substance CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Large Molecule Drug Substance CDMO Market Under COVID-19
4.7 Japan Large Molecule Drug Substance CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Large Molecule Drug Substance CDMO Market Under COVID-19
4.8 India Large Molecule Drug Substance CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Large Molecule Drug Substance CDMO Market Under COVID-19
4.9 Southeast Asia Large Molecule Drug Substance CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Large Molecule Drug Substance CDMO Market Under COVID-19
4.10 Latin America Large Molecule Drug Substance CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Large Molecule Drug Substance CDMO Market Under COVID-19
4.11 Middle East and Africa Large Molecule Drug Substance CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Large Molecule Drug Substance CDMO Market Under COVID-19
5 GLOBAL LARGE MOLECULE DRUG SUBSTANCE CDMO SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Large Molecule Drug Substance CDMO Sales Volume and Market Share by Type (2017-2022)
5.2 Global Large Molecule Drug Substance CDMO Revenue and Market Share by Type (2017-2022)
5.3 Global Large Molecule Drug Substance CDMO Price by Type (2017-2022)
5.4 Global Large Molecule Drug Substance CDMO Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Large Molecule Drug Substance CDMO Sales Volume, Revenue and Growth Rate of Contract Manufacturing (2017-2022)
5.4.2 Global Large Molecule Drug Substance CDMO Sales Volume, Revenue and Growth Rate of Contract Development (2017-2022)
6 GLOBAL LARGE MOLECULE DRUG SUBSTANCE CDMO MARKET ANALYSIS BY APPLICATION
6.1 Global Large Molecule Drug Substance CDMO Consumption and Market Share by Application (2017-2022)
6.2 Global Large Molecule Drug Substance CDMO Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Large Molecule Drug Substance CDMO Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Large Molecule Drug Substance CDMO Consumption and Growth Rate of Biotech Companies (2017-2022)
6.3.2 Global Large Molecule Drug Substance CDMO Consumption and Growth Rate of CRO (2017-2022)
6.3.3 Global Large Molecule Drug Substance CDMO Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL LARGE MOLECULE DRUG SUBSTANCE CDMO MARKET FORECAST (2022-2027)
7.1 Global Large Molecule Drug Substance CDMO Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Large Molecule Drug Substance CDMO Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Large Molecule Drug Substance CDMO Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Large Molecule Drug Substance CDMO Price and Trend Forecast (2022-2027)
7.2 Global Large Molecule Drug Substance CDMO Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Large Molecule Drug Substance CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Large Molecule Drug Substance CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Large Molecule Drug Substance CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Large Molecule Drug Substance CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Large Molecule Drug Substance CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Large Molecule Drug Substance CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Large Molecule Drug Substance CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Large Molecule Drug Substance CDMO Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Large Molecule Drug Substance CDMO Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Large Molecule Drug Substance CDMO Revenue and Growth Rate of Contract Manufacturing (2022-2027)
7.3.2 Global Large Molecule Drug Substance CDMO Revenue and Growth Rate of Contract Development (2022-2027)
7.4 Global Large Molecule Drug Substance CDMO Consumption Forecast by Application (2022-2027)
7.4.1 Global Large Molecule Drug Substance CDMO Consumption Value and Growth Rate of Biotech Companies(2022-2027)
7.4.2 Global Large Molecule Drug Substance CDMO Consumption Value and Growth Rate of CRO(2022-2027)
7.4.3 Global Large Molecule Drug Substance CDMO Consumption Value and Growth Rate of Others(2022-2027)
7.5 Large Molecule Drug Substance CDMO Market Forecast Under COVID-19
8 LARGE MOLECULE DRUG SUBSTANCE CDMO MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Large Molecule Drug Substance CDMO Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Large Molecule Drug Substance CDMO Analysis
8.6 Major Downstream Buyers of Large Molecule Drug Substance CDMO Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Large Molecule Drug Substance CDMO Industry
9 PLAYERS PROFILES
9.1 Samsung Biologics
9.1.1 Samsung Biologics Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Large Molecule Drug Substance CDMO Product Profiles, Application and Specification
9.1.3 Samsung Biologics Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Eurofins Scientific
9.2.1 Eurofins Scientific Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Large Molecule Drug Substance CDMO Product Profiles, Application and Specification
9.2.3 Eurofins Scientific Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 AGC Biologics
9.3.1 AGC Biologics Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Large Molecule Drug Substance CDMO Product Profiles, Application and Specification
9.3.3 AGC Biologics Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Catalent, Inc.
9.4.1 Catalent, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Large Molecule Drug Substance CDMO Product Profiles, Application and Specification
9.4.3 Catalent, Inc. Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Siegfried Holding AG
9.5.1 Siegfried Holding AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Large Molecule Drug Substance CDMO Product Profiles, Application and Specification
9.5.3 Siegfried Holding AG Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 LabCorp Drug Development, and FUJIFILM Diosynth Biotechnologies
9.6.1 LabCorp Drug Development, and FUJIFILM Diosynth Biotechnologies Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Large Molecule Drug Substance CDMO Product Profiles, Application and Specification
9.6.3 LabCorp Drug Development, and FUJIFILM Diosynth Biotechnologies Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Cambrex Corp.
9.7.1 Cambrex Corp. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Large Molecule Drug Substance CDMO Product Profiles, Application and Specification
9.7.3 Cambrex Corp. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 WuXi Biologics
9.8.1 WuXi Biologics Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Large Molecule Drug Substance CDMO Product Profiles, Application and Specification
9.8.3 WuXi Biologics Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Recipharm AB (publ)
9.9.1 Recipharm AB (publ) Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Large Molecule Drug Substance CDMO Product Profiles, Application and Specification
9.9.3 Recipharm AB (publ) Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Large Molecule Drug Substance CDMO Product Picture
Table Global Large Molecule Drug Substance CDMO Market Sales Volume and CAGR (%) Comparison by Type
Table Large Molecule Drug Substance CDMO Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Large Molecule Drug Substance CDMO Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Large Molecule Drug Substance CDMO Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Large Molecule Drug Substance CDMO Industry Development
Table Global Large Molecule Drug Substance CDMO Sales Volume by Player (2017-2022)
Table Global Large Molecule Drug Substance CDMO Sales Volume Share by Player (2017-2022)
Figure Global Large Molecule Drug Substance CDMO Sales Volume Share by Player in 2021
Table Large Molecule Drug Substance CDMO Revenue (Million USD) by Player (2017-2022)
Table Large Molecule Drug Substance CDMO Revenue Market Share by Player (2017-2022)
Table Large Molecule Drug Substance CDMO Price by Player (2017-2022)
Table Large Molecule Drug Substance CDMO Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Large Molecule Drug Substance CDMO Sales Volume, Region Wise (2017-2022)
Table Global Large Molecule Drug Substance CDMO Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Large Molecule Drug Substance CDMO Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Large Molecule Drug Substance CDMO Sales Volume Market Share, Region Wise in 2021
Table Global Large Molecule Drug Substance CDMO Revenue (Million USD), Region Wise (2017-2022)
Table Global Large Molecule Drug Substance CDMO Revenue Market Share, Region Wise (2017-2022)
Figure Global Large Molecule Drug Substance CDMO Revenue Market Share, Region Wise (2017-2022)
Figure Global Large Molecule Drug Substance CDMO Revenue Market Share, Region Wise in 2021
Table Global Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Large Molecule Drug Substance CDMO Sales Volume by Type (2017-2022)
Table Global Large Molecule Drug Substance CDMO Sales Volume Market Share by Type (2017-2022)
Figure Global Large Molecule Drug Substance CDMO Sales Volume Market Share by Type in 2021
Table Global Large Molecule Drug Substance CDMO Revenue (Million USD) by Type (2017-2022)
Table Global Large Molecule Drug Substance CDMO Revenue Market Share by Type (2017-2022)
Figure Global Large Molecule Drug Substance CDMO Revenue Market Share by Type in 2021
Table Large Molecule Drug Substance CDMO Price by Type (2017-2022)
Figure Global Large Molecule Drug Substance CDMO Sales Volume and Growth Rate of Contract Manufacturing (2017-2022)
Figure Global Large Molecule Drug Substance CDMO Revenue (Million USD) and Growth Rate of Contract Manufacturing (2017-2022)
Figure Global Large Molecule Drug Substance CDMO Sales Volume and Growth Rate of Contract Development (2017-2022)
Figure Global Large Molecule Drug Substance CDMO Revenue (Million USD) and Growth Rate of Contract Development (2017-2022)
Table Global Large Molecule Drug Substance CDMO Consumption by Application (2017-2022)
Table Global Large Molecule Drug Substance CDMO Consumption Market Share by Application (2017-2022)
Table Global Large Molecule Drug Substance CDMO Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Large Molecule Drug Substance CDMO Consumption Revenue Market Share by Application (2017-2022)
Table Global Large Molecule Drug Substance CDMO Consumption and Growth Rate of Biotech Companies (2017-2022)
Table Global Large Molecule Drug Substance CDMO Consumption and Growth Rate of CRO (2017-2022)
Table Global Large Molecule Drug Substance CDMO Consumption and Growth Rate of Others (2017-2022)
Figure Global Large Molecule Drug Substance CDMO Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Large Molecule Drug Substance CDMO Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Large Molecule Drug Substance CDMO Price and Trend Forecast (2022-2027)
Figure USA Large Molecule Drug Substance CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Large Molecule Drug Substance CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Large Molecule Drug Substance CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Large Molecule Drug Substance CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Large Molecule Drug Substance CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Large Molecule Drug Substance CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Large Molecule Drug Substance CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Large Molecule Drug Substance CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Large Molecule Drug Substance CDMO Market Sales Volume Forecast, by Type
Table Global Large Molecule Drug Substance CDMO Sales Volume Market Share Forecast, by Type
Table Global Large Molecule Drug Substance CDMO Market Revenue (Million USD) Forecast, by Type
Table Global Large Molecule Drug Substance CDMO Revenue Market Share Forecast, by Type
Table Global Large Molecule Drug Substance CDMO Price Forecast, by Type
Figure Global Large Molecule Drug Substance CDMO Revenue (Million USD) and Growth Rate of Contract Manufacturing (2022-2027)
Figure Global Large Molecule Drug Substance CDMO Revenue (Million USD) and Growth Rate of Contract Manufacturing (2022-2027)
Figure Global Large Molecule Drug Substance CDMO Revenue (Million USD) and Growth Rate of Contract Development (2022-2027)
Figure Global Large Molecule Drug Substance CDMO Revenue (Million USD) and Growth Rate of Contract Development (2022-2027)
Table Global Large Molecule Drug Substance CDMO Market Consumption Forecast, by Application
Table Global Large Molecule Drug Substance CDMO Consumption Market Share Forecast, by Application
Table Global Large Molecule Drug Substance CDMO Market Revenue (Million USD) Forecast, by Application
Table Global Large Molecule Drug Substance CDMO Revenue Market Share Forecast, by Application
Figure Global Large Molecule Drug Substance CDMO Consumption Value (Million USD) and Growth Rate of Biotech Companies (2022-2027)
Figure Global Large Molecule Drug Substance CDMO Consumption Value (Million USD) and Growth Rate of CRO (2022-2027)
Figure Global Large Molecule Drug Substance CDMO Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Large Molecule Drug Substance CDMO Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Samsung Biologics Profile
Table Samsung Biologics Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Samsung Biologics Large Molecule Drug Substance CDMO Sales Volume and Growth Rate
Figure Samsung Biologics Revenue (Million USD) Market Share 2017-2022
Table Eurofins Scientific Profile
Table Eurofins Scientific Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Eurofins Scientific Large Molecule Drug Substance CDMO Sales Volume and Growth Rate
Figure Eurofins Scientific Revenue (Million USD) Market Share 2017-2022
Table AGC Biologics Profile
Table AGC Biologics Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AGC Biologics Large Molecule Drug Substance CDMO Sales Volume and Growth Rate
Figure AGC Biologics Revenue (Million USD) Market Share 2017-2022
Table Catalent, Inc. Profile
Table Catalent, Inc. Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Catalent, Inc. Large Molecule Drug Substance CDMO Sales Volume and Growth Rate
Figure Catalent, Inc. Revenue (Million USD) Market Share 2017-2022
Table Siegfried Holding AG Profile
Table Siegfried Holding AG Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Siegfried Holding AG Large Molecule Drug Substance CDMO Sales Volume and Growth Rate
Figure Siegfried Holding AG Revenue (Million USD) Market Share 2017-2022
Table LabCorp Drug Development, and FUJIFILM Diosynth Biotechnologies Profile
Table LabCorp Drug Development, and FUJIFILM Diosynth Biotechnologies Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure LabCorp Drug Development, and FUJIFILM Diosynth Biotechnologies Large Molecule Drug Substance CDMO Sales Volume and Growth Rate
Figure LabCorp Drug Development, and FUJIFILM Diosynth Biotechnologies Revenue (Million USD) Market Share 2017-2022
Table Cambrex Corp. Profile
Table Cambrex Corp. Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cambrex Corp. Large Molecule Drug Substance CDMO Sales Volume and Growth Rate
Figure Cambrex Corp. Revenue (Million USD) Market Share 2017-2022
Table WuXi Biologics Profile
Table WuXi Biologics Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure WuXi Biologics Large Molecule Drug Substance CDMO Sales Volume and Growth Rate
Figure WuXi Biologics Revenue (Million USD) Market Share 2017-2022
Table Recipharm AB (publ) Profile
Table Recipharm AB (publ) Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Recipharm AB (publ) Large Molecule Drug Substance CDMO Sales Volume and Growth Rate
Figure Recipharm AB (publ) Revenue (Million USD) Market Share 2017-2022
Figure Large Molecule Drug Substance CDMO Product Picture
Table Global Large Molecule Drug Substance CDMO Market Sales Volume and CAGR (%) Comparison by Type
Table Large Molecule Drug Substance CDMO Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Large Molecule Drug Substance CDMO Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Large Molecule Drug Substance CDMO Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Large Molecule Drug Substance CDMO Industry Development
Table Global Large Molecule Drug Substance CDMO Sales Volume by Player (2017-2022)
Table Global Large Molecule Drug Substance CDMO Sales Volume Share by Player (2017-2022)
Figure Global Large Molecule Drug Substance CDMO Sales Volume Share by Player in 2021
Table Large Molecule Drug Substance CDMO Revenue (Million USD) by Player (2017-2022)
Table Large Molecule Drug Substance CDMO Revenue Market Share by Player (2017-2022)
Table Large Molecule Drug Substance CDMO Price by Player (2017-2022)
Table Large Molecule Drug Substance CDMO Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Large Molecule Drug Substance CDMO Sales Volume, Region Wise (2017-2022)
Table Global Large Molecule Drug Substance CDMO Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Large Molecule Drug Substance CDMO Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Large Molecule Drug Substance CDMO Sales Volume Market Share, Region Wise in 2021
Table Global Large Molecule Drug Substance CDMO Revenue (Million USD), Region Wise (2017-2022)
Table Global Large Molecule Drug Substance CDMO Revenue Market Share, Region Wise (2017-2022)
Figure Global Large Molecule Drug Substance CDMO Revenue Market Share, Region Wise (2017-2022)
Figure Global Large Molecule Drug Substance CDMO Revenue Market Share, Region Wise in 2021
Table Global Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Large Molecule Drug Substance CDMO Sales Volume by Type (2017-2022)
Table Global Large Molecule Drug Substance CDMO Sales Volume Market Share by Type (2017-2022)
Figure Global Large Molecule Drug Substance CDMO Sales Volume Market Share by Type in 2021
Table Global Large Molecule Drug Substance CDMO Revenue (Million USD) by Type (2017-2022)
Table Global Large Molecule Drug Substance CDMO Revenue Market Share by Type (2017-2022)
Figure Global Large Molecule Drug Substance CDMO Revenue Market Share by Type in 2021
Table Large Molecule Drug Substance CDMO Price by Type (2017-2022)
Figure Global Large Molecule Drug Substance CDMO Sales Volume and Growth Rate of Contract Manufacturing (2017-2022)
Figure Global Large Molecule Drug Substance CDMO Revenue (Million USD) and Growth Rate of Contract Manufacturing (2017-2022)
Figure Global Large Molecule Drug Substance CDMO Sales Volume and Growth Rate of Contract Development (2017-2022)
Figure Global Large Molecule Drug Substance CDMO Revenue (Million USD) and Growth Rate of Contract Development (2017-2022)
Table Global Large Molecule Drug Substance CDMO Consumption by Application (2017-2022)
Table Global Large Molecule Drug Substance CDMO Consumption Market Share by Application (2017-2022)
Table Global Large Molecule Drug Substance CDMO Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Large Molecule Drug Substance CDMO Consumption Revenue Market Share by Application (2017-2022)
Table Global Large Molecule Drug Substance CDMO Consumption and Growth Rate of Biotech Companies (2017-2022)
Table Global Large Molecule Drug Substance CDMO Consumption and Growth Rate of CRO (2017-2022)
Table Global Large Molecule Drug Substance CDMO Consumption and Growth Rate of Others (2017-2022)
Figure Global Large Molecule Drug Substance CDMO Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Large Molecule Drug Substance CDMO Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Large Molecule Drug Substance CDMO Price and Trend Forecast (2022-2027)
Figure USA Large Molecule Drug Substance CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Large Molecule Drug Substance CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Large Molecule Drug Substance CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Large Molecule Drug Substance CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Large Molecule Drug Substance CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Large Molecule Drug Substance CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Large Molecule Drug Substance CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Large Molecule Drug Substance CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Large Molecule Drug Substance CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Large Molecule Drug Substance CDMO Market Sales Volume Forecast, by Type
Table Global Large Molecule Drug Substance CDMO Sales Volume Market Share Forecast, by Type
Table Global Large Molecule Drug Substance CDMO Market Revenue (Million USD) Forecast, by Type
Table Global Large Molecule Drug Substance CDMO Revenue Market Share Forecast, by Type
Table Global Large Molecule Drug Substance CDMO Price Forecast, by Type
Figure Global Large Molecule Drug Substance CDMO Revenue (Million USD) and Growth Rate of Contract Manufacturing (2022-2027)
Figure Global Large Molecule Drug Substance CDMO Revenue (Million USD) and Growth Rate of Contract Manufacturing (2022-2027)
Figure Global Large Molecule Drug Substance CDMO Revenue (Million USD) and Growth Rate of Contract Development (2022-2027)
Figure Global Large Molecule Drug Substance CDMO Revenue (Million USD) and Growth Rate of Contract Development (2022-2027)
Table Global Large Molecule Drug Substance CDMO Market Consumption Forecast, by Application
Table Global Large Molecule Drug Substance CDMO Consumption Market Share Forecast, by Application
Table Global Large Molecule Drug Substance CDMO Market Revenue (Million USD) Forecast, by Application
Table Global Large Molecule Drug Substance CDMO Revenue Market Share Forecast, by Application
Figure Global Large Molecule Drug Substance CDMO Consumption Value (Million USD) and Growth Rate of Biotech Companies (2022-2027)
Figure Global Large Molecule Drug Substance CDMO Consumption Value (Million USD) and Growth Rate of CRO (2022-2027)
Figure Global Large Molecule Drug Substance CDMO Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Large Molecule Drug Substance CDMO Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Samsung Biologics Profile
Table Samsung Biologics Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Samsung Biologics Large Molecule Drug Substance CDMO Sales Volume and Growth Rate
Figure Samsung Biologics Revenue (Million USD) Market Share 2017-2022
Table Eurofins Scientific Profile
Table Eurofins Scientific Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Eurofins Scientific Large Molecule Drug Substance CDMO Sales Volume and Growth Rate
Figure Eurofins Scientific Revenue (Million USD) Market Share 2017-2022
Table AGC Biologics Profile
Table AGC Biologics Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AGC Biologics Large Molecule Drug Substance CDMO Sales Volume and Growth Rate
Figure AGC Biologics Revenue (Million USD) Market Share 2017-2022
Table Catalent, Inc. Profile
Table Catalent, Inc. Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Catalent, Inc. Large Molecule Drug Substance CDMO Sales Volume and Growth Rate
Figure Catalent, Inc. Revenue (Million USD) Market Share 2017-2022
Table Siegfried Holding AG Profile
Table Siegfried Holding AG Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Siegfried Holding AG Large Molecule Drug Substance CDMO Sales Volume and Growth Rate
Figure Siegfried Holding AG Revenue (Million USD) Market Share 2017-2022
Table LabCorp Drug Development, and FUJIFILM Diosynth Biotechnologies Profile
Table LabCorp Drug Development, and FUJIFILM Diosynth Biotechnologies Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure LabCorp Drug Development, and FUJIFILM Diosynth Biotechnologies Large Molecule Drug Substance CDMO Sales Volume and Growth Rate
Figure LabCorp Drug Development, and FUJIFILM Diosynth Biotechnologies Revenue (Million USD) Market Share 2017-2022
Table Cambrex Corp. Profile
Table Cambrex Corp. Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cambrex Corp. Large Molecule Drug Substance CDMO Sales Volume and Growth Rate
Figure Cambrex Corp. Revenue (Million USD) Market Share 2017-2022
Table WuXi Biologics Profile
Table WuXi Biologics Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure WuXi Biologics Large Molecule Drug Substance CDMO Sales Volume and Growth Rate
Figure WuXi Biologics Revenue (Million USD) Market Share 2017-2022
Table Recipharm AB (publ) Profile
Table Recipharm AB (publ) Large Molecule Drug Substance CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Recipharm AB (publ) Large Molecule Drug Substance CDMO Sales Volume and Growth Rate
Figure Recipharm AB (publ) Revenue (Million USD) Market Share 2017-2022
